Sign In
Buy TGT
$124.80
+1.64 (+1.33%)
At Close: Jun 03, 2026
Levels® Launches Strawberry Whey Protein at Target Stores in the U.S.
11:33am, Monday, 13'th Apr 2026
The minimal-ingredient, natural whey protein powder is now available in a 1.48 lb canister at select Target locations nationwide. JUPITER, Fla.
Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target
11:52pm, Saturday, 11'th Apr 2026
APLD's FQ3 earnings highlighted its HPC hosting segment's immense earnings upside potential, after reporting a 24.7% segment operating margin. Amendments to CoreWeave's leases de-risk the agreements a
Citi Cuts Docusign to Neutral With a $50 Target: Has the E-Signature Pioneer Lost Its Edge?
09:53am, Friday, 10'th Apr 2026
Citi has cut Docusign (NASDAQ:DOCU) shares to Neutral from Buy, setting a $50 price target that sits just above where the stock is currently trading.
Stock Market Today (LIVE): Court Greenlights Meta Addiction Suit; TSMC Revenue Hits Record High
09:50am, Friday, 10'th Apr 2026
Top insights from the latest market news from Friday, April 10, from The Motley Fool analysts on Team Rule Breakers and Team Hidden Gems.
Lam Research Has 14.73% Upside to Our $253.16 Target Based on Strong Earnings Growth
09:30am, Friday, 10'th Apr 2026
Lam Research (NASDAQ:LRCX | LRCX Price Prediction) trades at $220.65 as of April 7, 2026.
Mizuho Upgrades Shake Shack to Outperform With a $120 Target: Is the Fast Casual King Ready to Run?
09:13am, Friday, 10'th Apr 2026
Shake Shack (NYSE:SHAK) stock just got a fresh vote of confidence from Wall Street.
SSR Mining: Copler Drag Gone, Strong EPS, Hiking My Target
09:07am, Friday, 10'th Apr 2026
SSR Mining Inc. remains a Buy, with 10% intrinsic upside and strong technicals despite gold's correction below $5,000/oz. SSRM's Q4 results beat expectations: non-GAAP EPS $0.88 vs. $0.57 consensus, r
Piper Sandler Downgrades Nike to Neutral With a $50 Target: Can the Swoosh Find Its Footing Again?
09:00am, Friday, 10'th Apr 2026
Nike (NYSE:NKE) stock has been one of the market's most painful stories in 2026, and Piper Sandler just made its skepticism official.
Micron Has 15.58% Downside Risk to Our $318.89 Target Despite the 485.1% Rally
05:45am, Friday, 10'th Apr 2026
Micron Technology (NASDAQ:MU | MU Price Prediction) has risen 485.1% over the past year, but our model now flags a meaningful pullback risk.
Raiffeisen Takeover Target Addiko Gets Higher Offer From Slovenia's NLB
02:56am, Friday, 10'th Apr 2026
Nova Ljubljanska Banka's offer was at a premium of nearly 12% to the stock's closing price on Wednesday, and 26% higher than Raiffeisen's proposal.
Cars.com Provides Update on Business Initiatives, Raises Share Repurchase Target and Reaffirms Guidance
04:35pm, Thursday, 09'th Apr 2026
CHICAGO, April 9, 2026 /PRNewswire/ -- Cars.com Inc . (NYSE: CARS), a trusted audience-powered and data-driven technology platform that simplifies buying and selling cars, today shared an update on th
Cantor Launches Nebius With Overweight and a $129 Target: Is This the AI Infrastructure Stock Nobody Is Talking About?
11:06am, Thursday, 09'th Apr 2026
Nebius Group (NASDAQ:NBIS) stock just got its first vote of confidence from Cantor, which initiated coverage with an Overweight rating and a $129 price target.
Stifel Sets a $250 Price Target on Texas Instruments. Is This Semiconductor Giant Ready to Run?
10:49am, Thursday, 09'th Apr 2026
Texas Instruments (NASDAQ:TXN) stock got a confidence boost on Thursday when Stifel analyst Tore Svanberg upgraded the shares to Buy and assigned a fresh price target of $250, up from a prior target o
S&P 500 At 7,300? Tom Lee Sees Year-End Target In Sight Despite Possibility Of 'Inflation Shock'
07:30am, Thursday, 09'th Apr 2026
Fundstrat Head of Research Tom Lee believes the stock market has bottomed out and is on track to hit new record highs, maintaining a bold 7,300 target for the S&P 500 even as he warns of a looming mac
Cartography Biosciences Advances Strategic Oncology Collaboration with Gilead's First Option Target Exercise
07:30am, Thursday, 09'th Apr 2026
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cartography Biosciences, Inc., a clinical-stage biotechnology company advancing a differentiated pipeline of antibody-based cancer therapies, today announ
